459 related articles for article (PubMed ID: 21517801)
1. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses.
Stockfleth E; Zwingers T; Willers C
Eur J Dermatol; 2012; 22(3):370-4. PubMed ID: 22494856
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
[TBL] [Abstract][Full Text] [Related]
6. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
Nguyen HP; Rivers JK
Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
[TBL] [Abstract][Full Text] [Related]
7. Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.
Schlaak M; Simon JC
J Dtsch Dermatol Ges; 2010 Mar; 8(3):174-8. PubMed ID: 19889001
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose 5-fluorouracil/salicylic acid in actinic keratoses in relation to treatment duration.
Szeimies RM; Dirschka T; Prechtl A; Melzer A
J Dtsch Dermatol Ges; 2015 May; 13(5):430-8. PubMed ID: 25918087
[TBL] [Abstract][Full Text] [Related]
9. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment.
Jury CS; Ramraka-Jones VS; Gudi V; Herd RM
Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465
[TBL] [Abstract][Full Text] [Related]
11. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
12. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
[TBL] [Abstract][Full Text] [Related]
13. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
Nelson C; Rigel D; Smith S; Swanson N; Wolf J
J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
[TBL] [Abstract][Full Text] [Related]
14. Low-dose 5-fluorouracil in combination with salicylic acid for the treatment of actinic keratoses on the hands and/or forearms - results of a non-interventional study.
Reinhold U; Hadshiew I; Melzer A; Prechtl A
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):455-462. PubMed ID: 27549913
[TBL] [Abstract][Full Text] [Related]
15. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
[TBL] [Abstract][Full Text] [Related]
16. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
[TBL] [Abstract][Full Text] [Related]
17. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
[TBL] [Abstract][Full Text] [Related]
18. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
Mastrolonardo M
Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
[TBL] [Abstract][Full Text] [Related]
20. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
Van der Geer S; Krekels GA
J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
